GlassScriptPhysician profile
Jeffrey M Cohen
NPI 1104051630
$6,423.76
in general payments reported to CMS, 2019-2025
14 companies · $863 in 2025
The $863 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,033 · 2020: $120 · 2021: $748 · 2022: $1,175 · 2023: $1,582 · 2024: $903 · 2025: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,868 · Travel and Lodging: $338 · Entertainment: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,868.24 |
| Travel and Lodging | $338.00 |
| Entertainment | $141.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,702.12 | 2019-2025 | Acuvue |
| Coopervision INC. | $1,421.16 | 2019-2025 | Cvi Contact Lens, Myday Contact Lens, Paragon Crt |
| Alcon Vision LLC | $899.92 | 2019-2025 | Precision7, Total30, Precision 1 |
| Bausch & Lomb Americas INC. | $644.14 | 2022-2024 | Infuse |
| Glaukos Corporation | $475.88 | 2019-2025 | Idosetr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $385.73 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $255.84 | 2024-2025 | Xdemvy |
| Optos, INC. | $141.82 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Novartis Pharmaceuticals Corporation | $120.46 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $120.02 | 2019 | |
| Oyster Point Pharma, INC. | $110.42 | 2023 | Tyrvaya |
| Allergan, INC. | $100.17 | 2019 | |
| Abb Con-Cise Optical Group LLC | $29.08 | 2019 | |
| Menicon America INC | $17.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.